A better understanding of the mechanisms by which the RAS interacts with the ARC to control energy balance versus blood pressure will hopefully lead to additional advances in the quest to find novel and more selective anti-obesity therapies. The gene discussed is ARC; the disease is obesity due to melanocortin 4 receptor deficiency.